Pharvaris NV (PHVS)
37.92
+0.18
(+0.48%)
USD |
NASDAQ |
Sep 10, 13:49
Pharvaris EPS Diluted (Quarterly) : -0.8172 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.8172 |
| March 31, 2026 | -0.7023 |
| December 31, 2025 | -0.8343 |
| September 30, 2025 | -0.6971 |
| June 30, 2025 | -0.9426 |
| March 31, 2025 | -0.8951 |
| December 31, 2024 | -0.6827 |
| September 30, 2024 | -0.8474 |
| June 30, 2024 | -0.5934 |
| March 31, 2024 | -0.5658 |
| December 31, 2023 | -0.6735 |
| September 30, 2023 | -0.6275 |
| June 30, 2023 | -0.6896 |
| March 31, 2023 | -0.7179 |
| December 31, 2022 | -1.182 |
| September 30, 2022 | -0.2529 |
| June 30, 2022 | -0.40 |
| Date | Value |
|---|---|
| March 31, 2022 | -0.5426 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | -0.4597 |
| June 30, 2021 | -1.133 |
| March 31, 2021 | -0.795 |
| December 31, 2020 | -0.5344 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | -0.7895 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Novartis AG | 1.706 |
| BioAge Labs, Inc. | -0.582 |
| AstraZeneca PLC | 0.9849 |
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -55.63M |
| Total Expenses (Quarterly) | 55.63M |
| Enterprise Value | 2.286B |
| Earnings Yield | -8.05% |
| Normalized Earnings Yield | -8.045 |